CONMED
CNMD
145 hedge funds and large institutions have $1.13B invested in CONMED in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 60 reducing their positions, and 23 closing their positions.
279% more call options, than puts
Call options by funds: $1.57M | Put options by funds: $413K
6% less funds holding
Funds holding: 154 → 145 (-9)
17% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 60
18% less capital invested
Capital invested by funds: $1.37B → $1.13B (-$243M)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Top Buyers
Top Sellers
CNMD Hedge Fund Activity: Q3 2016 in Review
145 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2016, worth a combined $1.13B — down 18% from $1.37B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CNMD and 14 opened new positions — a net loss of 9 holders — while 60 trimmed existing stakes and 50 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $31.8M. The largest seller was Macquarie Group, cutting an estimated $21.6M.
- 145 institutional investors held CONMED (CNMD) as of Q3 2016, down from 154 in Q2 2016.
- Funds reported $1.13B of CONMED stock for Q3 2016, down 18% quarter-over-quarter.
- 14 funds opened new CONMED positions in Q3 2016 and 23 closed out, a net change of -9 holders.
- The largest CONMED buyer in Q3 2016 was Camber Capital Management, an estimated $31.8M added.
- The largest CONMED seller in Q3 2016 was Macquarie Group, an estimated $21.6M sold.
Based on aggregated 13F filings for Q3 2016.